 Subjects have a type of blood cell cancer, other blood disease or a genetic disease for which they received a stem cell transplant. After transplant while the immune system grows back the subjects have an infection with one or more of three viruses - Epstein Barr virus EBV, cytomegalovirus CMV or adenovirus - that has persisted or come back despite standard therapy. 